Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
In October 2021, I made a big call on Longeveron (NASDAQ:LGVN) stock, a biotech firm working on a promising Alzheimer’s therapy. Within six weeks, shares had risen over 11x… a stunning 1,000% ret...